These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6872203)

  • 1. Heterogeneity of lipoprotein electrophoretic patterns in patients with type IIa hyperlipoproteinemia.
    Hoeg JM; Papadopoulos NM; Gregg RE; Brewer HB
    Clin Chem; 1983 Aug; 29(8):1459-62. PubMed ID: 6872203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipoproteinemia phenotype determination by agarose gel electrophoresis updated.
    Papadopoulos NM
    Clin Chem; 1978 Feb; 24(2):227-9. PubMed ID: 627052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample.
    Kwiterovich PO; Heiss G; Johnson N; Chase GA; Tamir I; Rifkind B
    Am J Epidemiol; 1982 Feb; 115(2):192-204. PubMed ID: 7058778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.
    Schwandt P; Weisweiler P
    Atherosclerosis; 1980 Mar; 35(3):301-6. PubMed ID: 6987993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
    Shinomiya M; Ishikawa Y; Shirai K; Saito Y; Yoshida S
    Arzneimittelforschung; 1987 Sep; 37(9):1069-71. PubMed ID: 3435604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA
    Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjects.
    Yoshino G; Kazumi T; Iwai M; Iwatani I; Matsuba K; Kasama T; Matsushita M; Otsuki M; Baba S
    Atherosclerosis; 1988 Jun; 71(2-3):95-101. PubMed ID: 3135814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
    Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J; Goy-Loeper J; Rouffy J
    Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum lipoprotein pattern following bezafibrate. Differential effects in type IIa and in type IIb hyperlipoproteinemic patients.
    Sommariva D; Tirrito M; Bonfiglioli D; Pogliaghi I; Branchi A; Ottomano C; Bellintani L
    Pharmacol Res Commun; 1985 Dec; 17(12):1181-91. PubMed ID: 4095126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia.
    Wakatsuki A; Okatani Y; Ikenoue N
    Atherosclerosis; 2000 May; 150(1):103-11. PubMed ID: 10781640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M; Kuźmińska A; Chotkowska E; Kurjata P; Polakowska M; Broda G; Rywik S
    Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of thyroid hormones to human plasma lipoproteins.
    Benvenga S; Gregg RE; Robbins J
    J Clin Endocrinol Metab; 1988 Jul; 67(1):6-16. PubMed ID: 3379137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an automated immunoassay procedure for apo-LDL for phenotyping type II hyperlipoproteinemia.
    Nazir DJ; Brown PL; McQueen MJ
    Clin Chim Acta; 1978 Aug; 88(1):31-6. PubMed ID: 209916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.